not quite significantp = 0.072
In MDS, 35% (15/43) of patients displayed aberrant hypermethylation, a result that trended toward decreased survival but was not quite significant (HR 2.15, p = 0.072; Benetatos et al., 2009 ).
In MDS, 35% (15/43) of patients displayed aberrant hypermethylation, a result that trended toward decreased survival but was not quite significant (HR 2.15, p = 0.072; Benetatos et al., 2009 ).